Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionDiversified Trust Co
Latest Disclosed Ownership731 shares
Latest Disclosed Value $ 326,420
Diversified Trust Co reports 10.59% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On April 16, 2026 - Diversified Trust Co filed a 13F-HR form disclosing ownership of 731 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $326,421 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 661 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 10.59% during the quarter. The current value of the position is $313,117 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 731 70 10.59 326 9.03 0.0040
2026-01-09 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 661 50 8.18 300 25.10 0.0055
2025-10-20 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 611 -2 -0.33 239 -12.13 0.0048
2025-07-11 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 613 -19 -3.01 273 -11.11 0.0061
2025-04-24 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 632 95 17.69 306 41.67 0.0076
2025-01-07 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 537 -491 -47.76 216 -54.81 0.0053
2024-10-07 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,028 -522 -33.68 479 -34.16 0.0121
2024-07-16 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,550 95 6.53 727 19.41 0.0205
2024-04-18 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,455 -493 -25.31 608 -23.23 0.0183
2024-01-08 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,948 17 0.88 793 18.03 0.0266
2023-11-17 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,931 -454 -19.04 671 -20.02 0.0254
2023-07-18 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,385 786 49.16 839 66.80 0.0306
2023-04-07 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,599 -721 -31.08 504 -24.93 0.0196
2023-01-17 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,320 553 31.30 1 -100.00 0.0279
2022-10-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,767 497 39.13 512 43.02 0.0232
2022-07-12 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,270 -1,395 -52.35 358 -48.49 0.0150
2022-04-07 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,665 46 1.76 695 20.87 0.0243
2022-01-13 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,619 -535 -16.96 575 0.52 0.0189
2022-01-13 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,154 -489 -13.42 572 -22.18 0.0206
2021-07-20 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,643 337 10.19 735 3.52 0.0265
2021-05-10 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,306 107 3.34 710 -6.08 0.0274
2021-01-08 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,199 0 0.00 756 -13.20 0.0307
2020-10-15 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,199 1,232 62.63 871 52.54 0.0402
2020-07-07 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,967 330 20.16 571 46.41 0.0289
2020-04-10 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,637 11 0.68 390 9.55 0.0228
2020-01-09 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,626 1,626 356 0.0160
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.